Learn how simplifying a bipolar disorder treatment regimen, with a single agent acting as the “foundation” and others added when needed, may both improve patient morale and be effective for symptom control.
The Journal of Clinical Psychiatry
Insights April 15, 2021
Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder
J Clin Psychiatry 2020;81(4):OT19046AH1
Vol 87 • 2026 • Number 3
Read the Current Issue
Original Research
Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression
Original Research
US Mortality Involving Obesity and Psychiatric Disorders
Academic Highlights
Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report
Original Research
Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms
Original Research
Exposure-Based Video Therapy for OCD and PTSD
Original Research
